Number of the records: 1
trombospondíny
SYS d019699 LBL 00000nz--a2200000o--4500 005 20250606213338.9 008 970620|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D09.400.430.890.895 065 $a D12.776.395.550.895 065 $a D12.776.543.550.895 066 $a 01 $c 03 150 $a trombospondíny $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 665 $a 98; see THROMBOSPONDINS (NM) 1981-97 $2 eng 665 $a Glycoproteins (1981-1989) $2 eng 665 $a Membrane Glycoproteins (1989-1997) $2 eng 665 $a Platelet Membrane Glycoproteins (1992-1993) $2 eng 680 9-
$i A family of related, adhesive glycoproteins which are synthesized, secreted, and incorporated into the extracellular matrix of a variety of cells, including alpha granules of platelets following thrombin activation and endothelial cells. They interact with a number of BLOOD COAGULATION FACTORS and anticoagulant factors. Five distinct forms have been identified, thrombospondin 1, -2, -3, -4, and cartilage oligomeric matrix protein (COMP). They are involved in cell adhesion, platelet aggregation, cell proliferation, angiogenesis, tumor metastasis, VASCULAR SMOOTH MUSCLE growth, and tissue repair. $2 eng 680 $a membrane glycoproteins; THROMBOSPONDIN 1 is also available $2 eng 750 -2
$a Thrombospondins $2 eng 980 $x M
Number of the records: 1